These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22116600)

  • 1. Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol.
    Ouzaid I; Xylinas E; Campeggi A; Hoznek A; Vordos D; Abbou CC; Vacherot F; Salomon L; de la Taille A; Ploussard G
    World J Urol; 2013 Aug; 31(4):869-74. PubMed ID: 22116600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A solitary positive prostate cancer biopsy does not predict a unilateral lesion in radical prostatectomy specimens.
    Koie T; Mitsuzuka K; Narita S; Yoneyama T; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C
    Scand J Urol; 2015 Apr; 49(2):103-7. PubMed ID: 25165894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study.
    Ishizaki F; Hara N; Koike H; Kawaguchi M; Tadokoro A; Takizawa I; Nishiyama T; Takahashi K; Hohenfellner R
    Diagn Pathol; 2012 Jun; 7():68. PubMed ID: 22697234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
    Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
    BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, Turkey.
    Çelik S; Kızılay F; Yörükoğlu K; Aslan G; Ozen H; Akdogan B; Sozen S; Baltaci S; Muezzinoglu T; Izol V; Bayazıt Y; Narter F; Türkeri L;
    Urol Int; 2022; 106(1):35-43. PubMed ID: 33951662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can single positive core prostate cancer at biopsy be considered a low-risk disease?
    Yamamoto H; Koie T; Ookubo T; Mitsuzuka K; Narita S; Inoue T; Kawamura S; Kato T; Tochigi T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
    Int Urol Nephrol; 2018 Oct; 50(10):1829-1833. PubMed ID: 30128924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy.
    Beauval JB; Ploussard G; Cabarrou B; Roumiguié M; Ouzzane A; Gas J; Goujon A; Marcq G; Mathieu R; Vincendeau S; Cathelineau X; Mongiat-Artus P; Salomon L; Soulié M; Méjean A; de La Taille A; Rouprêt M; Rozet F;
    World J Urol; 2017 Aug; 35(8):1191-1197. PubMed ID: 27987030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological findings of radical prostatectomy specimens in Japanese men diagnosed on single core positive prostate biopsy in eight with a Gleason score less than 4.
    Miyake H; Ono Y; Park SJ; Hara I; Eto H
    Int J Urol; 2003 Jul; 10(7):383-6. PubMed ID: 12823693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve prostate biopsies detect significant cancer volumes (> 0.5 mL).
    Brössner C; Bayer G; Madersbacher S; Kuber W; Klingler C; Pycha A
    BJU Int; 2000 Apr; 85(6):705-7. PubMed ID: 10759670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.
    Bjurlin MA; Carter HB; Schellhammer P; Cookson MS; Gomella LG; Troyer D; Wheeler TM; Schlossberg S; Penson DF; Taneja SS
    J Urol; 2013 Jun; 189(6):2039-46. PubMed ID: 23485507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.
    Pierorazio PM; Ross AE; Lin BM; Epstein JI; Han M; Walsh PC; Partin AW; Pavlovich CP; Schaeffer EM
    BJU Int; 2012 Oct; 110(8):1122-8. PubMed ID: 22373045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer.
    Doshi C; Vacchio M; Attwood K; Murekeyisoni C; Mehedint DC; Badkhshan S; Azabdaftari G; Sule N; Guru KA; Mohler JL; Kauffman EC
    Prostate; 2016 Jun; 76(8):715-21. PubMed ID: 26880312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy.
    Ploussard G; Nicolaiew N; Marchand C; Terry S; Vacherot F; Vordos D; Allory Y; Abbou CC; Salomon L; de la Taille A
    Eur Urol; 2014 Jan; 65(1):154-61. PubMed ID: 22698576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.
    Villa L; Capitanio U; Briganti A; Abdollah F; Suardi N; Salonia A; Gallina A; Freschi M; Russo A; Castiglione F; Bianchi M; Rigatti P; Montorsi F; Scattoni V
    J Urol; 2013 Mar; 189(3):854-9. PubMed ID: 23022004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy.
    ElShafei A; Nyame Y; Kara O; Badawy A; Amujiogu I; Fareed K; Klein E; Jones JS
    J Urol; 2016 Jun; 195(6):1767-72. PubMed ID: 26724397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.